全文获取类型
收费全文 | 1612篇 |
免费 | 132篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 99篇 |
妇产科学 | 22篇 |
基础医学 | 146篇 |
口腔科学 | 34篇 |
临床医学 | 137篇 |
内科学 | 249篇 |
皮肤病学 | 30篇 |
神经病学 | 110篇 |
特种医学 | 148篇 |
外科学 | 157篇 |
综合类 | 154篇 |
一般理论 | 1篇 |
预防医学 | 187篇 |
眼科学 | 8篇 |
药学 | 124篇 |
中国医学 | 39篇 |
肿瘤学 | 110篇 |
出版年
2023年 | 8篇 |
2022年 | 16篇 |
2021年 | 25篇 |
2020年 | 23篇 |
2019年 | 23篇 |
2018年 | 28篇 |
2017年 | 25篇 |
2016年 | 21篇 |
2015年 | 33篇 |
2014年 | 54篇 |
2013年 | 54篇 |
2012年 | 67篇 |
2011年 | 68篇 |
2010年 | 82篇 |
2009年 | 77篇 |
2008年 | 53篇 |
2007年 | 53篇 |
2006年 | 83篇 |
2005年 | 52篇 |
2004年 | 39篇 |
2003年 | 35篇 |
2002年 | 28篇 |
2001年 | 39篇 |
2000年 | 40篇 |
1999年 | 45篇 |
1998年 | 51篇 |
1997年 | 66篇 |
1996年 | 58篇 |
1995年 | 47篇 |
1994年 | 36篇 |
1993年 | 38篇 |
1992年 | 22篇 |
1991年 | 22篇 |
1990年 | 23篇 |
1989年 | 46篇 |
1988年 | 41篇 |
1987年 | 29篇 |
1986年 | 28篇 |
1985年 | 20篇 |
1984年 | 22篇 |
1983年 | 11篇 |
1982年 | 16篇 |
1981年 | 10篇 |
1980年 | 17篇 |
1979年 | 10篇 |
1977年 | 10篇 |
1976年 | 11篇 |
1971年 | 5篇 |
1970年 | 5篇 |
1958年 | 4篇 |
排序方式: 共有1761条查询结果,搜索用时 10 毫秒
81.
82.
83.
Peripheral nerve disorders may be classified into compressive or entrapment neuropathies and non‐compressive neuropathies. Muscle denervation recognized on MRI may be a useful sign in the diagnosis of peripheral nerve disorders. Acute or subacute denervation results in prolonged T2 relaxation time, producing increased signal in skeletal muscle on short tau inversion‐recovery and fat‐suppressed T2‐weighted images. Chronic denervation produces fatty atrophy of skeletal muscles, resulting in increased muscle signal on T1‐weighted images. This review will outline and illustrate the various ways that muscle denervation as seen on MRI may assist in the diagnosis and localization of peripheral nerve disorders. 相似文献
84.
Dewan SA Majid 《Clinical and experimental pharmacology & physiology》2007,34(9):905-905
85.
ER Brown KA Charles SA Hoare RL Rye DI Jodrell RE Aird R Vora U Prabhakar M Nakada RE Corringham M DeWitte C Sturgeon D Propper FR Balkwill JF Smyth 《Annals of oncology》2008,19(7):1340-1346
BACKGROUND: Tumour necrosis factor-alpha (TNF-alpha) is an important regulator of the chronic inflammation contributing to tumour progression. Infliximab, an anti-TNF-alpha monoclonal antibody was investigated in this trial of patients with advanced cancer. The primary objectives were to determine the safety profile and biological response of infliximab in a cancer population. Clinical response was a secondary objective. PATIENTS AND METHODS: Forty-one patients received infliximab at 5 mg/kg (n = 21) or 10 mg/kg (n = 20) i.v. at 0 and 2 weeks and then every 4 weeks. Post-treatment samples were measured for changes in plasma and serum TNF-alpha, CCL2, IL-6 and C-reactive protein (CRP). RESULTS: Infliximab was well tolerated with no dose-limiting toxic effects. At both doses of infliximab, neutralisation of serum TNF-alpha was observed after 1 h while plasma CCL2, IL-6 and serum CRP were decreased 24 and 48 h following infliximab administration. Seven patients experienced disease stablisation (range 10-50+ weeks). There was no evidence of disease acceleration in any patient. CONCLUSIONS: Infliximab treatment was safe and well tolerated in patients with advanced cancer. There was evidence of biological activity with baseline TNF-alpha and CCL2 being correlated with infliximab response. 相似文献
86.
Beresford Buttery FRCOG FRACOG DDU COGUS Gregory Davison MRCOG FRACOG DDU COGUS Victor Hurley MRCOG FRACOG DDU COGUS Lachlan De Crespigny MD FRCOG FRACOG DDU COGUS Hugh P. Robinson MD FRCOG FRACOG DDU COGUS 《The Australian & New Zealand journal of obstetrics & gynaecology》1994,34(2):220-220
EDITORIAL COMMENT: We have published this letter in the position of an article to make sure that readers do not overlook it. The letter is signed by a number of specialist medical obstetrician ultmsonologists in Melbourne and they clearly state a different point of view to that expressed by Burrows, Ramsden and Frazer. (Aust NZ J Obstet Gynaecol 1993; 33:262–264). 相似文献
87.
A Ohlsson SA Calvert M Hosking AT Shennan 《Acta paediatrica (Oslo, Norway : 1992)》1992,81(10):751-756
This randomized controlled trial was designed to answer the question: does administration of dexamethasone to neonates with bronchopulmonary dysplasia decrease the need for assisted ventilation? Twenty-five infants with a birth weight < 1501 g, requiring mechanical ventilation and FiO2 of ± 0.30 at 21-35 days of age, were randomized to treatment with iv dexamethasone or to sham injections for 12 days. The primary outcome criterion was extubation within seven days after study entry. Treatment (n= 12) and control (n= 13) groups were well matched at entry. Dexamethasone facilitated weaning from assisted ventilation (p= 0.0154). There was no increased incidence of infection. Dexamethasone treatment resulted in a significant increase in glucosuria (p= 0.0002) and in systolic blood pressure (p= 0.0034). There was a significant decrease in heart rate (p= 0.0001) and a significant weight loss (p= 0.0002) following dexamethasone treatment. Dexamethasone treatment facilitated weaning from assisted ventilation but several systemic effects were noted that deserve further evaluation before dexamethasone becomes routine treatment. 相似文献
88.
Effects of positive and negative pressure ventilation on cerebral blood volume of newborn infants 总被引:3,自引:0,他引:3
KS Palmer SA Spencer YABD Wickramasinghe T Wright DP Southall P Rolfe 《Acta paediatrica (Oslo, Norway : 1992)》1995,84(2):132-139
The effects of intermittent positive airway and continuous negative extrathoracic pressure ventilation on cerebral blood volume in preterm infants were studied using near infrared spectroscopy. In 12 infants continuous negative extrathoracic pressure caused a median decrease in cerebral blood volume of 0.14ml/100ml brain (95% confidence intervals (CI) 0.035–0.280) compared with no respiratory support. Oxygenated and deoxygenated haemoglobin also decreased, implying increased venous drainage as the main effect. In 17 infants intermittent positive pressure ventilation also caused a median reduction in cerebral blood volume of 0.06 ml/100 ml brain (95% CI 0.010–0.115) compared with endotracheal positive airway pressure. Deoxygenated haemoglobin increased by 0.07 ml/100 ml brain (95% CI 0.010–0.100) while oxygenated haemoglobin decreased by O.lOml/lOOml brain (95% CI 0.005–0.175). The increase in deoxygenated haemoglobin implies decreased venous drainage and the decrease in oxygenated haemoglobin implies that other factors may also be significant. Heart rate, blood pressure and oxygen saturation were monitored continuously and remained stable. 相似文献
89.
90.
目的:通过对突发性聋病人血中一氧化氮(NO)、丙二醛(MDA)、超氧化物歧化酶(SOD)含量的检洲,探讨突聋与血氧自由基和自由基的清除剂SOD之间的关系。方法:采用硝酸还原酶法测定了30例突聋病人血中NO含量,并以25例同期体检正常的健康人为对照组;同时还用硫代巴比妥酸比色法测定MDA含量,用黄嘌呤氧化酶法测定SOD含量。砖呆;应用金纳多、能量合剂、克林臭(即马来酸桂哌齐特,钙通道阻滞药)联合静脉输入,突聋各组的听力均有不同程度提高,有效率在78.57%以上。治疗后同对照组相比,血清NO、MDA水平明显低于患病之初,而SOD活性明显高于治疗之前,P〈0.01。结论;检测突聋病人血中N0、MDA、SOD的含量,能帮助我们探讨突聋的发病机理,估计预后。血氧自由基的升高可能是突聋发病因素之一,而SOD的含量可以帮助我们估计预后。 相似文献